Synlogic, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

OTC.Pink
New Enterprise Associates 14, L.P. and affiliated entities have filed an amendment to their Schedule 13D, detailing their support for Synlogic, Inc.'s merger with Caldera Therapeutics, Inc.
OTC.Pink
Reporting persons Funicular Funds, LP, Cable Car Capital, LP, and Jacob Ma-Weaver have filed an amendment to their Schedule 13D, detailing their support for Synlogic's merger with Caldera Therapeutics, Inc.
OTC.Pink
Cable Car Capital and Funicular Funds propose to acquire Synlogic for $0.64 per share, representing a 28.3% stake.